{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T15:25:46Z","timestamp":1778167546517,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"51","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Disease","doi-asserted-by":"publisher","award":["R21AI103575"],"award-info":[{"award-number":["R21AI103575"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.vaccine.2015.10.124","type":"journal-article","created":{"date-parts":[[2015,11,6]],"date-time":"2015-11-06T16:31:31Z","timestamp":1446827491000},"page":"7217-7224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Efficacy of parainfluenza virus 5 (PIV5)-based tuberculosis vaccines in mice"],"prefix":"10.1016","volume":"33","author":[{"given":"Zhenhai","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuhina","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannon","family":"Phan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Pickar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilson","family":"Yau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell K.","family":"Karls","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick D.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biao","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.10.124_bib0225","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0230","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0235","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1164\/rccm.200411-1603OE","article-title":"The diagnosis and therapy of tuberculosis during the past 100 years","volume":"171","author":"Mitchison","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0240","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1001\/jama.293.22.2767","article-title":"Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally","volume":"293","author":"Dye","year":"2005","journal-title":"JAMA: J Am Med Assoc"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0245","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1476-0711-3-10","article-title":"A second-generation anti TB vaccine is long overdue","volume":"3","author":"Castanon-Arreola","year":"2004","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0250","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0020-7519(03)00061-4","article-title":"Recent progress in the development and testing of vaccines against human tuberculosis","volume":"33","author":"McMurray","year":"2003","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0255","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1054\/tube.2001.0308","article-title":"Global forum on TB vaccine research and development. World Health Organization, June 7\u20138 2001, Geneva","volume":"81","author":"Brennan","year":"2001","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0260","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.tube.2003.08.010","article-title":"Immunology of tuberculosis and implications in vaccine development","volume":"84","author":"Flynn","year":"2004","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0265","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1097\/00006454-199312000-00006","article-title":"Bacillus Calmette\u2013Guerin infection after vaccination of human immunodeficiency virus-infected children","volume":"12","author":"Besnard","year":"1993","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0270","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1086\/513642","article-title":"Disseminated bacille Calmette\u2013Guerin disease after vaccination: case report and review","volume":"24","author":"Talbot","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0275","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.4049\/jimmunol.174.5.2637","article-title":"The human CD1-restricted T cell repertoire is limited to cross-reactive antigens: implications for host responses against immunologically related pathogens","volume":"174","author":"Sieling","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0280","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1128\/IAI.71.6.3076-3087.2003","article-title":"T-cell responses to CD1-presented lipid antigens in humans with Mycobacterium tuberculosis infection","volume":"71","author":"Ulrichs","year":"2003","journal-title":"Infect Immunol"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0285","first-page":"11","article-title":"Animal models of tuberculosis for vaccine development","volume":"129","author":"Gupta","year":"2009","journal-title":"Indian J Med Res"},{"issue":"7 Suppl","key":"10.1016\/j.vaccine.2015.10.124_bib0290","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4161\/hv.7.0.14571","article-title":"Development of therapeutic and prophylactic vaccine against Tuberculosis using monkey and transgenic mice models","author":"Kita","year":"2011","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0295","doi-asserted-by":"crossref","first-page":"e5264","DOI":"10.1371\/journal.pone.0005264","article-title":"MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques","volume":"4","author":"Verreck","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0300","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"381","author":"Tameris","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0305","series-title":"Fields virology","article-title":"Paramyxoviridae the viruses and their replication","author":"Lamb","year":"2001"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0310","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3181\/00379727-126-32386","article-title":"Viruses recovered from laboratory dogs with respiratory disease","volume":"126","author":"Binn","year":"1967","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0315","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/oxfordjournals.aje.a121307","article-title":"Studies of canine respiratory viruses. I. Experimental infection of dogs with an SV5-like canine parainfluenza agent","volume":"94","author":"Rosenberg","year":"1971","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0320","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/vr.98.15.301","article-title":"Isolation of parainfluenza virus SV5 from dogs with respiratory disease","volume":"98","author":"Cornwell","year":"1976","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0325","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/vr.102.14.293","article-title":"A study of dogs with kennel cough","volume":"102","author":"McCandlish","year":"1978","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0330","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1292\/jvms1939.50.851","article-title":"Kennel cough complex: confirmation and analysis of the outbreak in Japan","volume":"50","author":"Azetaka","year":"1988","journal-title":"Nippon Juigaku Zasshi"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0335","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.2460\/ajvr.1981.42.10.1694","article-title":"Canine infectious tracheobronchitis: effects of an intranasal live canine parainfluenza-Bordetella bronchiseptica vaccine on viral shedding and clinical tracheobronchitis (kennel cough)","volume":"42","author":"Kontor","year":"1981","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0340","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/viro.1997.8801","article-title":"Recovery of infectious SV5 from cloned DNA and expression of a foreign gene","volume":"237","author":"He","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0345","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.virol.2011.08.020","article-title":"Comparison of differing cytopathic effects in human airway epithelium of parainfluenza virus 5 (W3A), parainfluenza virus type 3, and respiratory syncytial virus","volume":"421","author":"Zhang","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0350","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1128\/JVI.80.7.3416-3427.2006","article-title":"A simian virus 5 (SV5) P\/V mutant is less cytopathic than wild-type SV5 in human dendritic cells and is a more effective activator of dendritic cell maturation and function","volume":"80","author":"Arimilli","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0355","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1016\/j.vaccine.2014.03.049","article-title":"A respiratory syncytial virus (RSV) vaccine based on parainfluenza virus 5 (PIV5)","volume":"32","author":"Phan","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0360","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1128\/JVI.02321-12","article-title":"Recombinant parainfluenza virus 5 expressing hemagglutinin of influenza A virus H5N1 protected mice against lethal highly pathogenic avian influenza virus H5N1 challenge","volume":"87","author":"Li","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0365","doi-asserted-by":"crossref","first-page":"5985","DOI":"10.1128\/JVI.00120-13","article-title":"SIngle dose vaccination of a recombinant parainfluenza virus 5 expressing NP from H5N1 provides broad immunity against influenza A viruses","volume":"87","author":"Li","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0370","doi-asserted-by":"crossref","first-page":"9604","DOI":"10.1128\/JVI.01289-13","article-title":"Efficacy of parainfluenza virus 5 mutants expressing HA from H5N1 influenza A virus in mice","volume":"87","author":"Li","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0375","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1128\/JVI.02886-12","article-title":"A novel rabies vaccine based on a recombinant parainfluenza virus 5 expressing rabies virus glycoprotein","volume":"87","author":"Chen","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0380","doi-asserted-by":"crossref","first-page":"e50144","DOI":"10.1371\/journal.pone.0050144","article-title":"Evaluating a parainfluenza virus 5-based vaccine in a host with pre-existing immunity against parainfluenza virus 5","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0385","doi-asserted-by":"crossref","first-page":"e13162","DOI":"10.1371\/journal.pone.0013162","article-title":"Single-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 viruses","volume":"5","author":"Price","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0390","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1084\/jem.20072681","article-title":"The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development","volume":"205","author":"Sekaly","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0395","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1128\/JVI.68.6.3505-3511.1994","article-title":"Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challenge","volume":"68","author":"Lawson","year":"1994","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0400","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.1128\/JVI.73.8.6228-6234.1999","article-title":"Effect of inserting paramyxovirus simian virus 5 gene junctions at the HN\/L gene junction: analysis of accumulation of mRNAs transcribed from rescued viable viruses","volume":"73","author":"He","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0405","doi-asserted-by":"crossref","first-page":"7948","DOI":"10.4049\/jimmunol.181.11.7948","article-title":"Identification of human T cell antigens for the development of vaccines against Mycobacterium tuberculosis","volume":"181","author":"Bertholet","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0410","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.virol.2006.12.005","article-title":"Recombinant parainfluenza virus 5 (PIV5) expressing the influenza A virus hemagglutinin provides immunity in mice to influenza A virus challenge","volume":"362","author":"Tompkins","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0415","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1128\/JVI.02330-12","article-title":"Recombinant parainfluenza virus 5 vaccine encoding the influenza virus hemagglutinin protects against H5N1 highly pathogenic avian influenza virus infection following intranasal or intramuscular vaccination of BALB\/c mice","volume":"87","author":"Mooney","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0420","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1128\/JVI.80.4.1700-1709.2006","article-title":"Function of small hydrophobic proteins of paramyxovirus","volume":"80","author":"Wilson","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0425","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1128\/JVI.77.6.3371-3383.2003","article-title":"Induction of apoptosis by paramyxovirus simian virus 5 lacking a small hydrophobic gene","volume":"77","author":"Lin","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0430","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1006\/viro.1998.9354","article-title":"The paramyxovirus SV5 small hydrophobic (SH) protein is not essential for virus growth in tissue culture cells","volume":"250","author":"He","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0435","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1586\/erv.11.28","article-title":"Tuberculosis vaccines in clinical trials","volume":"10","author":"Rowland","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2015.10.124_bib0440","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1128\/JVI.75.7.3363-3370.2001","article-title":"Single amino acid substitution in the V protein of simian virus 5 differentiates its ability to block interferon signaling in human and murine cells","volume":"75","author":"Young","year":"2001","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15015807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15015807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T10:17:11Z","timestamp":1748686631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15015807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":44,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0264410X15015807"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.124","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of parainfluenza virus 5 (PIV5)-based tuberculosis vaccines in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}